ATRA: atarabio.com Kompaniya qiymatining sof foydaga nisbati
Atara Biotherapeutics (ATRA) siyosiy keskinliklar tufayli noyob reagentlarning yetishmasligiga duch kelmoqda, bu esa yangi dori vositalarining sertifikatlashtirilishiga to'sqinlik qilmoqda. Shu bilan birga, biznes biomateriallarning ishonchli tashilishi va yuqori marjalarni ta'minlovchi AQSh markazlarining keng tarmog'iga tayanadi. PE koeffitsiyenti -5.90 ni tashkil etadi. Laboratoriya avtomatlashtirishi va ma'lumotlar tahlili dasturiy ta'minotining joriy etilishi kunlik narxlar grafigida yanada yaqqol namoyon bo'lmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_ATRA_-_Atara-Biotherapeutics_-_PE-Multiple "ATRA: Atara Biotherapeutics Inc Biznesning o‘zini qoplash muddati 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
Atara Biotherapeutics, Inc. (ATRA) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Atara Biotherapeutics|ATRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Atara Biotherapeutics Inc|ATRA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Atara Bio|ATRA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Atara Biotherapeutics|Tezkor likvidlik koeffitsiyenti atarabio.com
- foyda va bozor multiplikatorlari tafsilotlari:
ATRA - Sof daromad|Kelajakdagi sof foyda Atara Biotherapeutics|ATRA - P/E multiplikatori|Forvard P/E multiplikatori Atara Biotherapeutics Inc|ATRA - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Atara Bio|ATRA - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Atara Biotherapeutics|ATRA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi atarabio.com|ATRA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Atara Biotherapeutics
Kompaniyaning har tomonlama tahlili:atarabio.com ATRA
Institutsional kapital Atara Biotherapeutics (ATRA) kompaniyasini hujayralar terapiyasi bo'yicha kelgusidagi muvaffaqiyatlar uchun to'langan premium miqdorini aniqlash maqsadida narx-foyda koeffitsienti prizmasi orqali baholaydi. Atara Biotherapeutics (ATRA) kompaniyasining P/E koeffitsiyenti dinamikasini tahlil qilish orqali investorlar R&D biologik xatarlarining aktivning adolatli qiymatiga qanday ta'sir qilishini ko'rishlari mumkin, bu esa iqtisodiy sikllardan qat'i nazar investitsiya ishonchliligini baholash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML - P/E multiplikatori|PGEN (Precigen, Inc.) - Narx-foyda koeffitsiyenti|PHAR: Bozor narxining sof foydaga nisbati|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|P/E multiplikatori Upstream Bio, Inc.|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|IMNM (Immunome Bio) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|P/E multiplikatori kalvista.com KALV|SEPN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PVLA (Pieris Pharma)|SVRA: P/E multiplikatori|RIGL (Rigel Corp) - Narxning foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati enGene (ENGN)|RAPT - Kapitalizatsiyaning foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|CABA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Ventyx Biosciences Inc. (VTYX)|Narxning foydaga nisbati Theratechnologies Inc|AVTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ELDN|P/E multiplikatori agenusbio.com (AGEN)|Narxning foydaga nisbati Climb Bio CLYM|ZURA (Zura Bio Ltd) - Kapitalizatsiyaning sof foydaga nisbati|aTyr - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Adagene|IMA (ikenaoncology.com) - Narx-foyda koeffitsiyenti|Shattuck Labs (STTK) - P/E multiplikatori|Narx-foyda koeffitsiyenti EQ|CNTB (Connect Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati inflarx.de|P/E multiplikatori XFOR (X4 Pharmaceuticals)|ACET - Narx-foyda koeffitsiyenti|CELU - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati INmune Bio Inc INMB|BRNS: P/E multiplikatori|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narx-foyda koeffitsiyenti SABS|AKTX (akaritx.com) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CARM|XTLB: P/E multiplikatori|Bolt Biotherapeutics, Inc. - Kompaniya qiymatining sof foydaga nisbati|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|ADTX (aditxt.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati GRI Bio GRI|XRTX - Narx-foyda koeffitsiyenti|ReShape Lifesciences - P/E multiplikatori|REVB - P/E multiplikatori|INDP (Indaptus Therapeutics) - Narx-foyda koeffitsiyenti|scinai.com - Kompaniya qiymatining sof foydaga nisbati|CALI (CalciMedica Inc) - P/E multiplikatori|Affimed Therapeutics (AFMD) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA: Narx-foyda koeffitsiyenti|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
